Kedudukan dalam Saham
#28557
PlexBio Co., Ltd. is dedicated to the creation and production of in vitro... PlexBio Co., Ltd. is dedicated to the creation and production of in vitro diagnostic (IVD) solutions for both molecular biology and immunology purposes. Their comprehensive product range features services for optimizing diagnostic workflows, as well as automated kits for sample preparation and extraction. A key innovation is their IntelliPlex platform, which leverages pCode technology to enable advanced, "sample-to-answer" multiplexing assays. The company also supplies specialized oncology panels designed for detecting lung cancer, gene mutations, and chromosomal rearrangements. Additionally, PlexBio offers a variety of infectious disease tests, including IntelliPlex kits for SARS-CoV-2 detection, influenza, and SARS-CoV-2 variant analysis, complemented by essential reagents such as pCode coupling buffer sets. Founded in 2009, PlexBio Co., Ltd. operates from its headquarters in Taipei, Taiwan.
Perubahan (1 tahun)
-24.39%
Perdagangan PlexBio Co., Ltd. (6572)
Harga 6572 dengan permodalan pasaran b
Modal pasaran bagi PlexBio Co., Ltd.(6572)
Modal Pasaran: $25.81M
Sehingga August 2026, PlexBio Co., Ltd. mempunyai modal pasaran sebanyak $25.81M. Ini menjadikan PlexBio Co., Ltd. syarikat ke-28557th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran PlexBio Co., Ltd. dari 2016 hingga 2026
6572 berbanding dengan 5 teratas yang paling popular stocks
| Harga 6572 |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.301T
|
+20,538,841.25%
|
|
|
|
|
$4.634T
|
+17,954,458.51%
|
|
|
|
|
$4.143T
|
+16,052,448.24%
|
|
|
|
|
$3.589T
|
+13,907,417.87%
|
|
|
|
|
$2.857T
|
+11,069,539.98%
|
